For prescribers in functional medicine and immunology, these peptides fill a gap that no FDA-approved product currently addresses
It should also be considered that relative to other CVOTs among patients with type 2 diabetes, the SAE rates in all the groups of the present analysis (9.113.0%) are quite low
These studies have provided abundant theoretical basis and empirical support for creating new methods to treat corneal injuries
PT-141 , known generically as bremelanotide and marketed as Vyleesi, is FDA-approved for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women
Best For: Uneven pigmentation, tanning, and dull complexion
Understanding how your gut bacteria respond to semaglutide helps explain why some patients consider adding probiotic support